Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Dev Cell ; 57(2): 246-259.e4, 2022 01 24.
Artículo en Inglés | MEDLINE | ID: mdl-35026163

RESUMEN

N6-methyladenosine (m6A) RNA modification confers an essential layer of gene regulation in living organisms, including plants; yet, the underlying mechanisms of its deposition on specific target mRNAs involved in key plant developmental processes are so far unknown. Here, we show that a core component of the rice m6A methyltransferase complex, OsFIP37, is recruited by an RNA-binding protein, OsFIP37-associated protein 1 (OsFAP1), to mediate m6A RNA modification on an auxin biosynthesis gene, OsYUCCA3, during microsporogenesis. This stabilizes OsYUCCA3 mRNA and promotes local auxin biosynthesis in anthers during male meiosis, which is essential for meiotic division and subsequent pollen development in rice. Loss of function of OsFAP1 causes dissociation of OsFIP37 with OsYUCCA3 and the resulting abolished m6A deposition on OsYUCCA3. Our findings reveal that OsFAP1-dependent m6A deposition on OsYUCCA3 by OsFIP37 constitutes a hitherto unknown link between RNA modification and hormonal control of male meiosis in plant reproductive development.


Asunto(s)
Adenosina/análogos & derivados , Ácidos Indolacéticos/metabolismo , Meiosis/genética , Adenosina/química , Adenosina/metabolismo , Flores/genética , Expresión Génica/genética , Regulación de la Expresión Génica de las Plantas/genética , Oryza/genética , Oryza/metabolismo , Desarrollo de la Planta/genética , Proteínas de Plantas/metabolismo , Polen/genética , ARN/genética , ARN/metabolismo , ARN Mensajero/genética , Proteínas de Unión al ARN/metabolismo
2.
Proteomics ; 15(11): 1884-905, 2015 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-25641954

RESUMEN

Thermosensitive genic male sterile (TGMS) rice line has made great economical contributions in rice production. However, the fertility of TGMS rice line during hybrid seed production is frequently influenced by low temperature, thus leading to its fertility/sterility alteration and hybrid seed production failure. To understand the mechanism of fertility alternation under low temperature inducement, the extracted proteins from young panicles of two TGMS rice lines at the fertility alternation sensitivity stage were analyzed by 2DE. Eighty-three protein spots were found to be significantly changed in abundance, and identified by MALDI-TOF-TOF MS. The identified proteins were involved in 16 metabolic pathways and cellular processes. The young panicles of TGMS rice line Zhu 1S possessed the lower ROS-scavenging, indole-3-acetic acid level, soluble protein, and sugar contents as well as the faster anther wall disintegration than those of TGMS rice line Zhun S. All these major differences might result in that the former is more stable in fertility than the latter. Based on the majority of the 83 identified proteins, together with microstructural, physiological, and biochemical results, a possible fertile alteration mechanism in the young panicles of TGMS rice line under low temperature inducement was proposed. Such a result will help us in breeding TGMS rice lines and production of hybrid seed.


Asunto(s)
Oryza/fisiología , Proteínas de Plantas/análisis , Proteómica/métodos , Ácido Abscísico/metabolismo , Antioxidantes/metabolismo , Frío , Electroforesis en Gel Bidimensional , Enzimas/metabolismo , Giberelinas/metabolismo , Ácidos Indolacéticos/metabolismo , Oryza/genética , Proteínas de Plantas/genética , Proteínas de Plantas/metabolismo , Polen/fisiología , Polen/ultraestructura , Prolina/metabolismo , Reproducción , Especificidad de la Especie , Espectrometría de Masa por Láser de Matriz Asistida de Ionización Desorción
3.
IET Nanobiotechnol ; 8(1): 31-6, 2014 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-24888189

RESUMEN

This work mainly describes an electrochemical microsensor based on the reduction of molybdophosphate complex for total phosphorus (TP) determinations in water. The microelectrode was fabricated using microelectromechanical systems (MEMS) techniques and porous, branching gold nanoparticles (AuNPs) were electrodeposited on the microelectrode to improve its sensitivity. Calibration of the microsensor was performed with standard phosphate solutions prepared with KH2PO4 with pH adjusted to 1.0. The experimental results showed that both sensitivity and current response are improved effectively using this modified microelectrodes: The limit of detection of the microsensor is 1.2 x 10(-7) mol/l and linear range is 3 x 10(-7) to 3 x 10(-4) mol/l. The sensitivity of unmodified electrode is -0.27nA/micromol x 1(-1) (R2 = 0.994), whereas the sensitivity of AuNPs modified electrode is -0.89 nA/micromol 1(-1) (R2 = 0.8). The current response of modified electrode is 6 times larger than that of unmodified electrode in average. Detection of TP was also carried out with digested TP standard solutions for both modified and unmodified electrodes, and results were consistent with the nominal value of phosphorus concentration. This microsensor provides the probability of combining TP detection device with micro-digesting device to form a TP detection system, which can realise the automotive and on-line monitoring of TP in surface water.


Asunto(s)
Conductometría/instrumentación , Monitoreo del Ambiente/instrumentación , Oro/química , Nanopartículas del Metal/química , Microelectrodos , Fósforo/análisis , Contaminantes Químicos del Agua/análisis , Adsorción , Diseño de Equipo , Análisis de Falla de Equipo , Nanopartículas del Metal/ultraestructura , Miniaturización , Transductores
4.
Science ; 328(5975): 240-3, 2010 Apr 09.
Artículo en Inglés | MEDLINE | ID: mdl-20378816

RESUMEN

Arsenic, an ancient drug used in traditional Chinese medicine, has attracted worldwide interest because it shows substantial anticancer activity in patients with acute promyelocytic leukemia (APL). Arsenic trioxide (As2O3) exerts its therapeutic effect by promoting degradation of an oncogenic protein that drives the growth of APL cells, PML-RARalpha (a fusion protein containing sequences from the PML zinc finger protein and retinoic acid receptor alpha). PML and PML-RARalpha degradation is triggered by their SUMOylation, but the mechanism by which As2O3 induces this posttranslational modification is unclear. Here we show that arsenic binds directly to cysteine residues in zinc fingers located within the RBCC domain of PML-RARalpha and PML. Arsenic binding induces PML oligomerization, which increases its interaction with the small ubiquitin-like protein modifier (SUMO)-conjugating enzyme UBC9, resulting in enhanced SUMOylation and degradation. The identification of PML as a direct target of As2O3 provides new insights into the drug's mechanism of action and its specificity for APL.


Asunto(s)
Arsénico/metabolismo , Arsenicales/metabolismo , Arsenicales/farmacología , Proteínas Nucleares/metabolismo , Proteínas de Fusión Oncogénica/metabolismo , Óxidos/metabolismo , Óxidos/farmacología , Factores de Transcripción/metabolismo , Proteínas Supresoras de Tumor/metabolismo , Trióxido de Arsénico , Línea Celular , Humanos , Leucemia Promielocítica Aguda/tratamiento farmacológico , Leucemia Promielocítica Aguda/genética , Proteínas Mutantes/química , Proteínas Mutantes/metabolismo , Mutación , Proteínas Nucleares/química , Proteínas Nucleares/genética , Proteínas de Fusión Oncogénica/química , Proteínas de Fusión Oncogénica/genética , Oxazinas/metabolismo , Proteína de la Leucemia Promielocítica , Conformación Proteica , Multimerización de Proteína , Estructura Secundaria de Proteína , Estructura Terciaria de Proteína , Receptores de Ácido Retinoico/metabolismo , Proteínas Recombinantes de Fusión/química , Proteínas Recombinantes de Fusión/metabolismo , Receptor alfa de Ácido Retinoico , Proteínas Modificadoras Pequeñas Relacionadas con Ubiquitina/metabolismo , Espectrometría de Masa por Láser de Matriz Asistida de Ionización Desorción , Factores de Transcripción/química , Factores de Transcripción/genética , Proteínas Supresoras de Tumor/química , Proteínas Supresoras de Tumor/genética , Ubiquitinación , Dedos de Zinc
5.
Cancer Biol Ther ; 1(6): 614-20, 2002.
Artículo en Inglés | MEDLINE | ID: mdl-12642682

RESUMEN

Most acute promyelocytic leukemia (APL) cases have t(15;17)(q22;q21) chromosomal translocation and PML-RARalpha chimeric gene which blocks granulocytic differentiation. The introduction of all-trans-retinoic acid (ATRA) and arsenic compounds, especially arsenic trioxide (As(2)O(3)), has provided good models to study not only differentiation and/or apoptosis therapy but also molecular target-based cancer treatment. In vivo and in vitro investigations have shown that both agents are able to induce differentiation of APL cells: ATRA tends to induce terminal differentiation, while low-dose As(2)O(3) can induce partial differentiation. Significant progress has been made in understanding the molecular mechanisms of APL pathogenesis and differentiation therapy. Pharmacological concentrations (0.1 approximately 1 microM) of ATRA derepresses transcription by releasing CoR from, and recruiting CoA to PML-RARalpha, whereas As(2)O(3) triggers a rapid degradation of PML-RARalpha. In fact, the two drugs act on the same oncoprotein through targeting different moieties and in distinct ways and thereby abrogate its dominant-negative effects on regulatory pathways necessary for granulocytic differentiation. As to apoptosis, it is clear that high-dose As(2)O(3) can induce mitochondria-mediated cell death pathway in a thiol-dependent manner, while the mechanism of ATRA-induced apoptosis needs further elucidation. Transcriptomic and proteomic analysis are also expected to find new molecular targets. It is the hope that what we have learnt from APL will benefit further developments of anti-leukemia therapy.


Asunto(s)
Antineoplásicos/uso terapéutico , Arsenicales/uso terapéutico , Leucemia Promielocítica Aguda/tratamiento farmacológico , Óxidos/uso terapéutico , Tretinoina/uso terapéutico , Animales , Apoptosis/efectos de los fármacos , Trióxido de Arsénico , Diferenciación Celular/efectos de los fármacos , Resistencia a Antineoplásicos , Sinergismo Farmacológico , Humanos , Leucemia Promielocítica Aguda/patología , Proteínas de Neoplasias/efectos de los fármacos , Proteínas de Fusión Oncogénica/efectos de los fármacos , Translocación Genética/genética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA